# Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report

## TL;DR

A new treatment combining bronchoscopy and pembrolizumab showed promising results in a rare and aggressive lung cancer case.

## Contribution

Combining bronchoscopic therapy with pembrolizumab offers a novel treatment strategy for pulmonary large cell neuroendocrine carcinoma.

## Key findings

- The combination therapy led to significant clinical improvement in a patient with LCNEC.
- This approach demonstrates potential for managing this aggressive form of lung cancer.

## Abstract

This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.

Bronchoscopic interventional therapy combined with pembrolizumab in the treatment of Large cell neuroendocrine carcinoma of the lung has achieved good results.